Related Experiment Videos
MLP-CKD: a clinically informed deep learning framework for admission laboratory-based screening and risk
Xueliang Chen1, Hao Yang2,3, Yunxia Huang1
1Department of Nephrology, Pujiang County People's Hospital, Jinhua, Zhejiang, China.
A new deep learning model, MLP-CKD, effectively screens and stratifies risk for advanced kidney dysfunction using routine lab tests. Its clinically informed feature grouping significantly improves performance in identifying patients with uremia-associated renal dysfunction.
Area of Science:
- Artificial Intelligence in Medicine
- Nephrology
- Critical Care Medicine
Background:
- Advanced renal dysfunction, particularly uremia-associated, poses significant clinical challenges.
- Early screening and risk stratification are crucial for timely intervention and improved patient outcomes.
- Current methods may not fully leverage the predictive power of routine laboratory data.
Purpose of the Study:
- To develop and validate a deep learning framework (MLP-CKD) for screening and risk stratification of uremia-associated advanced renal dysfunction.
- To assess the model's performance against conventional machine learning and rule-based approaches.
- To identify key drivers of model performance, particularly the role of clinically informed feature grouping.
Main Methods:
- Utilized the MIMIC-IV database, extracting laboratory measurements from adult ICU patients within 24 hours of admission.
- Developed MLP-CKD, a multi-branch multilayer perceptron incorporating clinical domain grouping and missingness indicators.
- Compared MLP-CKD against XGBoost, random forest, and an eGFR rule-based baseline using discrimination, calibration, and decision curve analysis.
Main Results:
- MLP-CKD achieved an AUC of 0.913 and AUPRC of 0.848 on an independent test set, outperforming other models.
- Clinically informed feature grouping was identified as the primary driver of performance, with interaction modules offering incremental benefits.
- The model demonstrated superior discrimination compared to XGBoost, random forest, and the eGFR baseline.
Conclusions:
- MLP-CKD offers a clinically structured framework for screening and risk stratification of uremia-associated advanced renal dysfunction.
- The model's strength lies in its clinically informed feature grouping, providing competitive discrimination.
- MLP-CKD serves as a valuable decision-support tool for clinicians, rather than a standalone diagnostic system.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care